ST Elevation Acute Myocardial InfarctionNCT07568587
Myocardial Function Recovery Prediction Post Primary PCI Using the Estimate of Myocardial Salvage in Gated SPECT Early After Acute Myocardial Infarction
An observational study of ST Elevation Acute Myocardial Infarction, run by Fayoum University at 1 site in Egypt.
Trial summary
Our aim was to correlate functional and perfusion abnormalities early post primary percutaneous coronary intervention after acute myocardial infarction in ST elevation myocardial infarction patients to estimate myocardial salvage, and to predict left ventricular ejection fraction (LVEF) recovery and remodeling in… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- ST Elevation Acute Myocardial Infarction
- How many people
- 30 participants
- Where
- 1 siteEgypt
- Study dates
- 9 Oct 2021to 21 Apr 2026
- How long will I take part?
- 6 Months
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: The study population is a consecutive cohort of patients post primary PCI at Kasr Al-Aini Cardiac Centre, Cairo University.
Who may be able to join
- STEMI patients underwent primary PCI.
Who cannot join
- Patients who were lost to follow-up at 6 months post index-SPECT MPI study.
- Patients subsequently underwent a coronary revascularization procedure [percutaneous coronary intervention (PCI) or coronary bypass surgery (CABG)] within 60 days post index-SPECT MPI post PCI.
- Patients had a documented history of prior MI or coronary revascularization
- Patients with severe valvular disease and/or non-ischemic cardiomyopathy.
- Patients with renal and/or hepatic critical illness.
Trial locations and contacts
1 site in 1 country.
About this study
Our aim was to correlate functional and perfusion abnormalities early post primary percutaneous coronary intervention after acute myocardial infarction in ST elevation myocardial infarction patients to estimate myocardial salvage, and to predict left ventricular ejection fraction (LVEF) recovery and remodeling in gated SPECT at follow-up.
Read the detailed description
Myocardial Salvage and Infarction Size assessed by an early gated Single Photon Emission Computed Tomography Myocardial Perfusion Image study can predict Left Ventricle Ejection Fraction evolution after primary Percutaneous Coronary Intervention for Acute Myocardial Infarction.
- Conditions
- ST Elevation Acute Myocardial Infarction
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| ST Elevation Myocardial Infarction patients | Primary PCI |
What is being measured
The primary outcome is the main question the study is designed to answer.
Myocardial Salvage assessed by an early gated SPECT Myocardial Perfusion Image study can predict LVEF evolution after primary PCI for Acute Myocardial Infarction.
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 May 2026
- Study start9 Oct 2021
- Primary completion21 Apr 2026
- Study completion21 Apr 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for ST Elevation Acute Myocardial InfarctionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 30 participants (actual)
- Target duration
- 6 Months
Sponsor and investigators
- Lead sponsor
- Fayoum University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ebraam Thabet Amin Faheem, Fayoum University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07568587
- Sponsor's protocol ID
- D 308
- Status last verified
- Oct 2021
- First submitted
- 21 Apr 2026
- Last updated
- 6 May 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 6 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Myocardial Function Recovery Prediction Post Primary PCI Using the Estimate of Myocardial Salvage in Gated SPECT Early After Acute Myocardial Infarction
- ClinicalTrials.gov ID
- NCT07568587
- Acronym / sponsor ID
- D 308
- Conditions
- ST Elevation Acute Myocardial Infarction
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- Fayoum UniversityUniversity, hospital or other
- Study start
- 9 Oct 2021 (actual)
- Primary completion
- 21 Apr 2026 (actual)
- Study completion
- 21 Apr 2026 (actual)
- First posted
- 6 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Our aim was to correlate functional and perfusion abnormalities early post primary percutaneous coronary intervention after acute myocardial infarction in ST elevation myocardial infarction patients to estimate myocardial salvage, and to predict left ventricular ejection fraction (LVEF) recovery and remodeling in gated SPECT at follow-up.
Detailed description
Myocardial Salvage and Infarction Size assessed by an early gated Single Photon Emission Computed Tomography Myocardial Perfusion Image study can predict Left Ventricle Ejection Fraction evolution after primary Percutaneous Coronary Intervention for Acute Myocardial Infarction.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 6 Months
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| ST Elevation Myocardial Infarction patients | – | –Primary PCI |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- The study population is a consecutive cohort of patients post primary PCI at Kasr Al-Aini Cardiac Centre, Cairo University.
Key inclusion criteria (1 listed)
- STEMI patients underwent primary PCI.
Key exclusion criteria (5 listed)
- Patients who were lost to follow-up at 6 months post index-SPECT MPI study.
- Patients subsequently underwent a coronary revascularization procedure [percutaneous coronary intervention (PCI) or coronary bypass surgery (CABG)] within 60 days post index-SPECT MPI post PCI.
- Patients had a documented history of prior MI or coronary revascularization
- Patients with severe valvular disease and/or non-ischemic cardiomyopathy.
- Patients with renal and/or hepatic critical illness.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Myocardial Salvage assessed by an early gated SPECT Myocardial Perfusion Image study can predict LVEF evolution after primary PCI for Acute Myocardial Infarction.
Time frame: 6 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 May 2026.
Related trials for ST Elevation Acute Myocardial Infarction
Active, not recruiting
Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease
Acute Myocardial Infarction, Coronary Artery Disease
Not yet recruitingObservational study
AI-ECG Detection of Occlusion Myocardial Infarction at Emergency Department Triage (TRIACS)
Acute Coronary Syndromes, Chest Pain
Not yet recruitingPhase 4
IMPROVE-STEMI: pPCI Plus Low-dose r-SK in STEMI
ST Elevation Myocardial Infarction (STEMI)
RecruitingObservational study
Analysis of Life-threatening ARrhythMias After Acute Coronary Syndrome
Acute Coronary Syndromes (ACS), Ventricular Tachycardia (VT)
Not yet recruitingObservational study
On vs Off-hour PPCI in STEMI Patients
Acute STEMI, PPCI
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of ST Elevation Acute Myocardial Infarction, run by Fayoum University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 6 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Myocardial Salvage assessed by an early gated SPECT Myocardial Perfusion Image study can predict LVEF evolution after primary PCI for Acute Myocardial Infarction. (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 May 2026.